Sugammadex use in patients with end-stage renal disease: a historical cohort study.

Stephania ParedesSteven B PorterIvan E PorterJohnathan R Renew

Published in: Canadian journal of anaesthesia = Journal canadien d'anesthesie (2020)

We provide incremental evidence that SGX could be considered as an alternative neuromuscular blockade reversal agent in patients with ESRD.

Keyphrases